I now have comprehensive data from both textbooks. Let me compile the full clinical guide.
Hypoglycemia and Hyperglycemia: OPD & ER Management Guidelines
PART 1 - HYPOGLYCEMIA
Definition & Classification
Hypoglycemia in a diabetic patient is defined as a blood glucose
≤70 mg/dL (3.9 mmol/L). The ADA classification (from
Goldman-Cecil Medicine) is:
| Category | Definition |
|---|
| Severe | Any episode with neurocognitive impairment requiring third-party assistance |
| Documented symptomatic | BG ≤70 mg/dL + autonomic/neurologic symptoms; self-managed |
| Asymptomatic | BG ≤70 mg/dL, no symptoms (may reflect hypoglycemia unawareness) |
| Pseudo-hypoglycemia | Typical symptoms but BG >70 mg/dL (common in poorly controlled patients) |
Symptoms
| Autonomic (early warning) | Neuroglycopenic (late/severe) | General |
|---|
| Sweating, palpitations, shaking, hunger | Confusion, drowsiness, odd behavior, speech difficulty, incoordination | Headache, nausea |
When glucose continues to drop: progressive confusion, loss of consciousness, seizures, and potentially fatal cardiac arrhythmias (QTc prolongation, ventricular dysrhythmias from catecholamine surge).
OPD/ER Management - "Rule of 15"
Step 1 - Conscious, able to swallow:
- Give 15-20 g fast-acting carbohydrate orally:
- 150-200 mL fruit juice or glucose drink
- 3-4 glucose tablets
- 1 tablespoon sugar dissolved in water
- Recheck glucose in 15 minutes
- If BG still <72 mg/dL (4.0 mmol/L), repeat oral carbohydrate up to 3 times
- After recovery, give a long-acting carbohydrate snack (bread, biscuit) to prevent rebound
Step 2 - Confused/semi-cooperative (cannot safely swallow):
- Squeeze 2 tubes of 40% dextrose gel between gum and cheek (buccal absorption)
- Consider intranasal glucagon (new formulation - now available and safe)
- If no IV access available: Glucagon 1 mg IM or SC (thigh or deltoid)
Step 3 - Unconscious, seizing, or unable to protect airway (ER):
- IV Dextrose 50% (D50W) - 25-50 mL IV push (= 12.5-25 g dextrose)
- Alternatively: Glucagon 1 mg IM if IV access delayed
- Monitor glucose every 15-30 minutes after treatment
- Basic life support if needed
- Admit for observation if: sulfonylurea-induced (prolonged action), insulin overdose, recurrent episodes, or unexplained cause
Special case - Sulfonylurea-induced hypoglycemia (ER):
- Dextrose alone may cause paradoxical rebound hypoglycemia (stimulates more insulin release)
- Add Octreotide 50-100 mcg SC after 1st or 2nd recurrent episode to suppress insulin secretion
- Serial injections every 6-8 hours or constant IV infusion 125 mcg/h may be needed
- These patients often require 24-hour observation
Post-episode (OPD follow-up):
- Identify and address the cause: missed meals, excess insulin/sulfonylurea dose, alcohol, exercise
- Adjust medication doses
- Educate patient and family on recognition and "Rule of 15"
- Screen for hypoglycemia unawareness (needs lower glycemic targets, CGM consideration)
- Nocturnal hypoglycemia prevention: bedtime cornstarch snack, switch to ultra-long-acting insulins (glargine U300, degludec)
PART 2 - HYPERGLYCEMIA: DKA and HHS
Diagnostic Criteria
DKA (ADA Criteria):
| Severity | Glucose (mg/dL) | pH | HCO3 (mmol/L) | Ketones | Anion Gap | Mental Status |
|---|
| Mild | >250 | 7.25-7.30 | 15-18 | Positive | >10 | Alert |
| Moderate | >250 | 7.0-7.24 | 10-15 | Positive | >12 | Alert/drowsy |
| Severe | >250 | <7.0 | <10 | Positive | >12 | Stupor/coma |
The three core features of DKA: Hyperglycemia (D) + Ketonemia/ketonuria ≥2+ or ≥3.0 mmol/L (K) + pH <7.3 or HCO3 <18 (A).
HHS (Hyperosmolar Hyperglycemic State):
- Glucose typically >600 mg/dL (often >800-1000 mg/dL)
- Serum osmolarity >320 mOsm/kg
- pH >7.30, HCO3 >18 (minimal ketosis, though some overlap with DKA exists)
- Altered sensorium correlates with severity of hyperosmolarity
- Occurs mainly in elderly type 2 diabetics
Common precipitants (both DKA and HHS):
Infection (most common), insulin nonadherence, new-onset diabetes, acute coronary syndrome, stroke, pancreatitis, medications (glucocorticoids, SGLT2 inhibitors), surgery/trauma, alcohol, drugs (cocaine, antipsychotics)
Initial ER Workup
- Bedside glucose (rapid)
- Venous blood gas (pH - venous pH ~0.03 lower than arterial; arterial BGA usually not needed)
- Serum electrolytes (Na, K, Cl, HCO3)
- Anion gap = Na - (Cl + HCO3) - normal 8-12
- BUN, creatinine (prerenal azotemia expected)
- Beta-hydroxybutyrate (quantitative - >3 mmol/L confirms DKA; more reliable than urine dipstick ketones which only detect acetoacetate)
- CBC (leukocytosis - may be from acidosis alone; WBC >25,000 or fever suggests infection)
- Serum phosphate, magnesium, calcium
- ECG (assess for hyperkalemia/hypokalemia, and rule out MI as precipitant)
- Urinalysis + urine ketones
- Blood cultures, CXR if infection suspected
- Corrected sodium = measured Na + 2.4 × [(glucose - 100)/100]
DKA Management (ER)
Treatment follows four simultaneous pillars:
1. IV Fluids (Highest Priority - Start Immediately)
- 0.9% Normal Saline (NS) 1 L in first hour (resuscitation)
- Continue at 250-500 mL/h based on hydration status
- Typical total deficit: 3-6 L
- When glucose falls to ≤250 mg/dL: add 10% Dextrose to the NS - do NOT stop insulin; this "dual bag" approach allows continued insulin infusion to clear ketones
- Switch to 0.45% NS once patient is euvolemic to avoid hyperchloremic acidosis
2. Potassium Replacement (Do Before or With Insulin If K+ Low)
| Initial K+ | Action |
|---|
| <3.3 mEq/L | Hold insulin - replace K+ at 20-30 mEq/h IV until K+ ≥3.5 mEq/L |
| 3.3-5.2 mEq/L | Start insulin + add 20-30 mEq K+ per liter of IV fluid |
| >5.2 mEq/L | Start insulin, hold K+ replacement; recheck K+ every 2 hours |
- Monitor K+ every 2 hours during first phase
- Target K+ 4.0-5.0 mEq/L
- Cardiac monitoring recommended for severe hypokalemia
- Oral K+ is preferred as soon as tolerated
- Typical total K+ replacement in first 24h: 100-200 mEq
3. Insulin
- Start only after K+ ≥3.5 mEq/L is confirmed
- Regular insulin IV infusion at 0.1-0.14 units/kg/h (no bolus needed in most patients)
- Alternatively: 0.1 unit/kg IV bolus then 0.1 unit/kg/h infusion
- Target glucose drop: 50-75 mg/dL/h
- If glucose not dropping after 1 hour: check IV line, then increase rate
- When glucose ≤250 mg/dL AND pH >7.3 AND HCO3 ≥18: reduce insulin to 0.05 units/kg/h, add dextrose to IV fluid
- Resolution criteria: glucose <200, HCO3 ≥15, venous pH >7.3, anion gap closed
- Transition to subcutaneous insulin: Overlap SC insulin with IV infusion by 1-2 hours before stopping infusion (prevents rebound ketosis)
- Continue background long-acting SC insulin throughout treatment if patient was already on it
4. Bicarbonate
- Not routinely recommended - risk of paradoxical CNS acidosis and worsening hypokalemia
- Consider only if pH <7.0 and patient not responding to fluids + insulin
- If given: 100 mEq NaHCO3 in 400 mL sterile water + 20 mEq KCl over 2 hours
HHS Management (ER)
- Fluids are the primary treatment - more aggressive replacement needed than DKA (deficit 8-10 L)
- 0.9% NS 1 L/h for first 2-4 hours, then reassess
- Switch to 0.45% NS once hemodynamically stable (to reduce osmolarity gradually)
- Goal: reduce osmolarity by no more than 3-8 mOsm/kg/h to prevent cerebral edema
- Insulin: Start at 0.05 units/kg/h (lower than DKA) - fluids alone will often lower glucose initially; start insulin when glucose stops falling with fluids alone
- Potassium replacement same as DKA
- Glucose target: 250-300 mg/dL initially (do not drop too fast)
- Thromboprophylaxis should be considered - elderly HHS patients are high risk for DVT/stroke
Cerebral Edema Prevention (especially in children and young adults with DKA):
- Reduce osmolality slowly
- Avoid large volumes of hypotonic fluids
- Do not allow serum Na+ to fall during treatment
- Avoid unnecessary bicarbonate
- Avoid hypoxia, hypokalemia, hypophosphatemia
Criteria for ICU vs. Floor Admission
| ICU | Floor/Monitored Unit |
|---|
| Severe DKA (pH <7.0), coma, hemodynamic instability | Mild-moderate DKA, anion gap <25 |
| HHS with altered consciousness | Glucose <600 mg/dL, no comorbidity |
| Refractory hypokalemia or hyperkalemia | Patient tolerating oral fluids early |
| Need for airway management | Nursing staff experienced with insulin infusions |
- Patients presenting early who tolerate oral fluids may be managed in ER/observation and discharged after 6-12 hours of therapy
Discharge/OPD Follow-Up After Hyperglycemic Crisis
- Identify and address precipitant
- Restart or optimize insulin regimen before discharge
- Educate: sick-day rules (never stop insulin during illness, monitor more frequently)
- Recurrent DKA: address access barriers, insulin storage, psychosocial factors, consider CGM
- OPD follow-up within 1-2 weeks
- Review HbA1c and adjust long-term management
Quick Reference Summary Card
HYPOGLYCEMIA
BG ≤70 mg/dL
Conscious → 15g carbs PO → recheck 15 min → repeat x3
Unconscious → D50W 25-50 mL IV OR Glucagon 1 mg IM
Sulfonylurea → add Octreotide 50 mcg SC, observe 24h
DKA (Glucose >250 + Ketones + pH <7.3)
1. NS 1 L/h IVF → switch to D10+NS when BG ≤250
2. K+ check → hold insulin if K+ <3.3; replace to ≥3.5 first
3. Insulin: 0.1 unit/kg/h IV → reduce when BG ≤250
4. Bicarb: ONLY if pH <7.0
5. Overlap SC insulin 1-2h before stopping infusion
HHS (Glucose >600 + Osmolarity >320)
1. Aggressive IVF (8-10 L deficit) - NS → 0.45%NS
2. Reduce osmolarity slowly (<3-8 mOsm/kg/h)
3. Insulin 0.05 unit/kg/h after BG plateaus
4. Thromboprophylaxis in elderly
Sources:
- Goldman-Cecil Medicine, 26th Ed. - Chapters 210, 211 (Hypoglycemia, DKA, HHS)
- Tintinalli's Emergency Medicine, 9th Ed. - Chapters 224, 225 (Hypoglycemia ER management, DKA ER management)
- ADA Standards of Care 2025 (released Dec 2024) - updated CGM guidance, hyperglycemic crisis protocols